231. Alpha-1-antitrypsin deficiency Clinical trials / Disease details


Clinical trials : 93 Drugs : 77 - (DrugBank : 8) / Drug target genes : 10 - Drug target pathways : 36

  
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT03008915
(ClinicalTrials.gov)
January 201722/12/2016Targeting Pulmonary Perfusion in Alpha-1 Antitrypsin DeficiencyTargeting Pulmonary Perfusion in Alpha-1 Antitrypsin DeficiencyAlpha-1 Antitrypsin Deficiency;Emphysema;Chronic Obstructive Pulmonary DiseaseDrug: Aspirin;Drug: Placebo;Other: Withdrawal from alpha1 antitrypsin replacement therapyColumbia UniversityAlpha-1 Foundation;Stony Wold-Herbert Fund, Inc.Active, not recruiting40 YearsN/AAll15Phase 2United States